These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Endoscopic treatment for high grade vesicoureteral reflux in infants. Dawrant MJ; Mohanan N; Puri P J Urol; 2006 Oct; 176(4 Pt 2):1847-50. PubMed ID: 16945670 [TBL] [Abstract][Full Text] [Related]
31. Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetrafluoroethylene. Chertin B; De Caluwé D; Puri P J Urol; 2003 May; 169(5):1847-9; discussion 1849. PubMed ID: 12686860 [TBL] [Abstract][Full Text] [Related]
32. Renal ultrasound studies after endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. Yu RN; Jones EA; Roth DR Urology; 2006 Oct; 68(4):866-8; discussion 868-9. PubMed ID: 17070369 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms of failure of endoscopic treatment of vesicoureteral reflux based on endoscopic anatomy. Diamond DA; Caldamone AA; Bauer SB; Retik AB J Urol; 2003 Oct; 170(4 Pt 2):1556-8; discussion 1559. PubMed ID: 14501659 [TBL] [Abstract][Full Text] [Related]
34. Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation. Elmore JM; Kirsch AJ; Heiss EA; Gilchrist A; Scherz HC J Urol; 2008 Jun; 179(6):2364-7; discussion 2367-8. PubMed ID: 18436248 [TBL] [Abstract][Full Text] [Related]
35. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux. Chi A; Gupta A; Snodgrass W J Urol; 2008 May; 179(5):1966-9. PubMed ID: 18355849 [TBL] [Abstract][Full Text] [Related]
36. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. Routh JC; Reinberg Y; Ashley RA; Inman BA; Wolpert JJ; Vandersteen DR; Husmann DA; Kramer SA J Urol; 2007 Oct; 178(4 Pt 2):1702-5; discussion 1705-6. PubMed ID: 17707019 [TBL] [Abstract][Full Text] [Related]
37. Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction. Läckgren G; Sköldenberg E; Stenberg A J Urol; 2007 Mar; 177(3):1124-8; discussion 1128-9. PubMed ID: 17296428 [TBL] [Abstract][Full Text] [Related]
38. Long-term preservation of dextranomer/hyaluronic acid copolymer implants after endoscopic treatment of vesicoureteral reflux in children: a sonographic volumetric analysis. McMann LP; Scherz HC; Kirsch AJ J Urol; 2007 Jan; 177(1):316-20; discussion 320. PubMed ID: 17162076 [TBL] [Abstract][Full Text] [Related]
39. The role of endoscopic treatment in the management of grade v primary vesicoureteral reflux. Menezes MN; Puri P Eur Urol; 2007 Nov; 52(5):1505-9. PubMed ID: 17517467 [TBL] [Abstract][Full Text] [Related]
40. Endoscopic subureteral glutaraldehyde cross-linked collagen injection for the treatment of secondary vesicoureteral reflux: comparison with primary vesicoureteral reflux in adults. Inoue K; Nakamoto T; Usui A; Usui T J Urol; 2000 Aug; 164(2):336-9. PubMed ID: 10893579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]